TL-925 is a first in class, topical Bruton’s tyrosine kinase (BTK) inhibitor that prevents mast cell activation and degranulation, and also blocks the cytokine-driven inflammatory response, and restores lacrimal unit homeostasis, offering the potential for disease modification
Jeff Todd, president and CEO of Prevent Blindness, and astrophotographer Jon Carmichael sat down with David Hutton of Ophthalmology Times to talk about how ophthalmologists can help make sure patients are viewing the eclipse safely as well as proper ways to view/photograph the event without damaging your eyes or equipment.
According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.
Study concluded that the short-term results of LBN to treat mild-to-modern OAG and OHT was safe and efficacious.
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them
The company has divested its Coherus Ophthalmology subsidiary to Sandoz, Inc. for upfront all-cash consideration of $170 million.
Early detection of the disease is key to optimal patient outcomes
News
Eyenovia acquired the US commercial rights for the drug last August from Formosa Pharmaceuticals.
Investigators believe that AMD and cancer may have similar risk factors in common.
Day 2 program of the 2024 COPHy conference.
Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation
The approval marks the first new steroid on the US ophthalmic market in more than 15 years
The approval marks the first new steroid on the ophthalmic market in more than 15 years.
The 2024 15th annual Controversies in Ophthalmology Congress will convene March 15 and 16 in Athens, Greece.
ChatGPT-4 (OpenAI) had an overall “fair” performance when answering multiple-choice ophthalmic questions unrelated to multifocal imaging.
Andrew G. Iwach, MD, recounts two personal life experiences that underscore the significance of patient-centered care in glaucoma management.
Early detection of the disease is key to optimal patient outcomes
A longitudinal, AI-based approach to fluid quantification
News
After completing his residency at the Wilmer Eye Institute and a fellowship at NIH, Walter J. Stark, MD, returned to Wilmer for a 40-year career as a surgeon, teacher, researcher, and Boone Pickens Professor of Ophthalmology and chief of the Cornea Division.
During the 2024 American Glaucoma Society meeting held February 29 to March 3 in Huntington Beach, California, Nixoc SA presented posters outlining data on NCX 470.
Mobile cameras allow University of Colorado ophthalmology residents working in hospital settings to conduct more comprehensive and efficient patient evaluations.
David Sola-Del Valle, MD, sat down with David Hutton of Ophthalmology Times to discuss his talk at the annual American Glaucoma Society meeting held in Huntington Beach, about the importance of bridging the language barrier in patients who may not be fluent in English.
April Maa, MD, sat down with David Hutton of Ophthalmology Times to discuss her presentation at the annual American Glaucoma Society meeting held in Huntington Beach, about tips and tricks for implementing telehealth into ophthalmology.
Repetitive exercises before drop instillation, may decrease difficulty and improve the successful instillation of eye drops.
Mentorship, leadership and addressing bias are key areas for improvement
In the trial, PL9643 failed to meet co-primary and secondary endpoints.
In ophthalmology, women continue to take on leadership roles and make a difference in the profession.
